Citadel Advisors’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $307K | Buy |
514,443
+483,917
| +1,585% | +$282K | ﹤0.01% | 10418 |
|
|
2025
Q4 | $17.7K | Buy |
+30,526
| New | +$12.3K | ﹤0.01% | 12365 |
|
|
2025
Q3 | – | Sell |
-1,040,070
| Closed | -$1.72M | – | 14534 |
|
|
2025
Q2 | $1.72M | Sell |
1,040,070
-60,259
| -5% | -$78.3K | ﹤0.01% | 5999 |
|
|
2025
Q1 | $1.74M | Sell |
1,100,329
-130,128
| -11% | -$320K | ﹤0.01% | 5802 |
|
|
2024
Q4 | $4.12M | Buy |
1,230,457
+43,044
| +4% | +$113K | ﹤0.01% | 4283 |
|
|
2024
Q3 | $2.23M | Sell |
1,187,413
-23,653
| -2% | -$44.8K | ﹤0.01% | 5321 |
|
|
2024
Q2 | $2.39M | Buy |
1,211,066
+29,978
| +3% | +$74.8K | ﹤0.01% | 4990 |
|
|
2024
Q1 | $3.63M | Hold |
1,181,088
| – | – | ﹤0.01% | 4476 |
|
|
2023
Q4 | $2.75M | Buy |
+1,181,088
| New | +$3.68M | ﹤0.01% | 4802 |
|
|
2023
Q1 | – | Sell |
-2,997
| Closed | -$8.09K | – | 15674 |
|
|
2022
Q4 | $8.09K | Sell |
2,997
-1,815
| -38% | -$7.25K | ﹤0.01% | 13769 |
|
|
2022
Q3 | $19K | Buy |
+4,812
| New | +$30.8K | ﹤0.01% | 12094 |
|
|
2022
Q2 | – | Sell |
-2,477
| Closed | -$20.8K | – | 14421 |
|
|
2022
Q1 | $29K | Buy |
2,477
+674
| +37% | +$8.01K | ﹤0.01% | 13121 |
|
|
2021
Q4 | $33K | Sell |
1,803
-1,470
| -45% | -$31.6K | ﹤0.01% | 13442 |
|
|
2021
Q3 | $81K | Buy |
3,273
+1,447
| +79% | +$56.1K | ﹤0.01% | 13064 |
|
|
2021
Q2 | $116K | Buy |
+1,826
| New | +$145K | ﹤0.01% | 12781 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 13907 |
|
|
2020
Q3 | – | Sell |
-7,020
| Closed | -$875K | – | 10938 |
|
|
2020
Q2 | $875K | Buy |
7,020
+6,800
| +3,091% | +$921K | ﹤0.01% | 6070 |
|
|
2020
Q1 | $42K | Buy |
+220
| New | +$69K | ﹤0.01% | 9104 |
|
|
2019
Q1 | – | Sell |
-193
| Closed | -$57K | – | 10019 |
|
|
2018
Q4 | $57K | Buy |
+193
| New | +$86.4K | ﹤0.01% | 8457 |
|
|
2018
Q3 | – | Sell |
-223
| Closed | -$130K | – | 9826 |
|
|
2018
Q2 | $130K | Buy |
223
+25
| +13% | +$19.4K | ﹤0.01% | 8127 |
|
|
2018
Q1 | $535K | Buy |
+198
| New | +$482K | ﹤0.01% | 5771 |
|
Other funds holding VYNE
AFM
NCM
LCM
SC
ACM
TC
B
KCA
